Management of breast cancer in very young women

Breast

Volumn 22, Issue S2, 2013, Pages

  Freedman, Rachel A ^a   Partridge, Ann H ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Age; Breast cancer; Premenopausal; Young women

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; EXEMESTANE; TAMOXIFEN; TRASTUZUMAB; TRIPTORELIN; ZOLEDRONIC ACID;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL DECISION MAKING; DRUG EFFICACY; FEMALE; GENE MUTATION; HUMAN; MOLECULAR PATHOLOGY; PARTIAL MASTECTOMY; PREMENOPAUSE; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT INDICATION; TUMOR SUPPRESSOR GENE; WOMEN'S HEALTH;

AGE; BREAST CANCER; PREMENOPAUSAL; YOUNG WOMEN;

ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LONG-TERM CARE; MASTECTOMY, SEGMENTAL; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; PREMENOPAUSE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAMOXIFEN; YOUNG ADULT;

EID: 84884722123     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.034     Document Type: Article

References (43)

1. American Cancer Society Breast cancer facts & figures 2011-2012 2012, American Cancer Society, Inc, Atlanta.
2. SEER cancer statistics review, 1975-2009 2012, 2012. National Cancer Institute, Bethesda, MD, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2009/.
3. Porter P. Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 2008, 358(3):213-216.
4. Johnson R.H., Chien F.L., Bleyer A. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA: J Am Med Assoc. 2013, 309(8):800-805.
5. Xiong Q., Valero V., Kau V., Kau S.W., Taylor S., Smith T.L., et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 2001, 92(10):2523-2528.
6. Zabicki K., Colbert J.A., Dominguez F.J., Gadd M.A., Hughes K.S., Jones J.L., et al. Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol 2006, 13(8):1072-1077.
7. Sidoni A., Cavaliere A., Bellezza G., Scheibel M., Bucciarelli E. Breast cancer in young women: clinicopathological features and biological specificity. Breast 2003, 12(4):247-250.
8. Kapp J.M., Walker R., Haneuse S., Buist D.S., Yankaskas B.C. Are there racial/ethnic disparities among women younger than 40 undergoing mammography?. Breast Cancer Res Treat 2010, 124(1):213-222.
9. Azim H.A., Michiels S., Bedard P.L., Singhal S.K., Criscitiello C., Ignatiadis M., et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res Off J Am Assoc Cancer Res. 2012, 18(5):1341-1351.
10. Collins L.C., Marotti J.D., Gelber S., Cole K., Ruddy K., Kereakoglow S., et al. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 2012, 131(3):1061-1066.
11. Partridge A.H., Hughes M.E., Ottesen R.A., Wong Y.N., Edge S.B., Theriault R.L., et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist 2012, 17(6):775-782.
12. Shavers V.L., Harlan L.C., Stevens J.L. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 2003, 97(1):134-147.
13. Adami H.O., Malker B., Holmberg L., Persson I., Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986, 315(9):559-563.
14. Arvold N.D., Taghian A.G., Niemierko A., Abi Raad R.F., Sreedhara M., Nguyen P.L., et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 2011, 29(29):3885-3891.
15. Partridge A.H., Gelber S., Piccart M., Focant F., Scullion M., Holmes E. The effect of age on breast cancer outcomes in women with her-2 positive breast cancer: results from the HERA trial. J Clin Oncol 2013, 44:2692-2698.
16. Partridge A.H., Hughes M.E., Ottesen R.A., Wong Y.N., Edge S.B., Theriault R.L., et al. age and survival in women with early stage breast cancer: analysis controlling for tumor subtype. Presented at the 2011 San Antonio breast cancer symposium (manuscript in preparation) 2011, Abstract # P1-08-5.
17. Keegan T.H., DeRouen M.C., Press D.J., Kurian A.W., Clarke C.A. Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res BCR 2012, 14(2):R55.
18. Chau C. The distribution of Recurrence Scores from 21-gene breast cancer assay in the Asia Pacific region compared with the United States 2013, [cited 2013 July 29, 2013]; Available from. http://www.oncotypedx.com.
19. Anders C.K., Acharya C.R., Hsu D.S., Broadwater G., Garman K., Foekens J.A., et al. Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS ONE 2008, 3(1):e1373.
20. Anders C.K., Fan C., Parker J.S., Carey L.A., Blackwell K.L., Klauber-DeMore N., et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?. J Clin Oncol Off J Am Soc Clin Oncol 2011, 29(1):e18-e20.
21. Carey L.A., Perou C.M., Livasy C.A., Dressler L.G., Cowan D., Conway K., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295(21):2492-2502.
22. Kroman N., Holtveg H., Wohlfahrt J., Jensen M.B., Mouridsen H.T., Blichert-Toft M., et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004, 100(4):688-693.
23. Mahmood U., Morris C., Neuner G., Koshy M., Kesmodel S., Buras R., et al. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012, 83(5):1387-1393.
24. Leong C., Boyages J., Jayasinghe U.W., Bilous M., Ung O., Chua B., et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004, 100(9):1823-1832.
25. Jobsen J.J., Van Der Palen J., Ong F., Meerwaldt J.H. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Acta Oncol 2007, 46(2):172-180.
26. Beadle B.M., Woodward W.A., Tucker S.L., Outlaw E.D., Allen P.K., Oh J.L., et al. Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 2009, 73(3):734-744.
27. Freedman R.A., Virgo K.S., Labadie J., He Y., Partridge A.H., Keating N.L. Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat 2012, 135(3):893-906.
28. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365(9472):1687-1717.
29. De Laurentiis M., Cancello G., D'Agostino D., Giuliano M., Giordano A., Montagna E., et al. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol Off J Am Soc Clin Oncol 2008, 26(1):44-53.
30. Freedman R.A., Partridge A.H. Adjuvant therapies for very young women with early stage breast cancer. Breast 2011, 20(Suppl 3):S146-S149.
31. Ruddy K., Gelber S., Tamimi R., Ginsberg E., Schapira L., Come S., et al. Fertility Concerns in Young Women with Breast Cancer: Results from a Prospective Cohort Study. J Clin Oncol 2011, 29. suppl; abstr 6025.
32. Ruddy K.J., Partridge A.H. Breast cancer in young women: clinical decision-making in the face of uncertainty. Oncology (Williston Park) 2009, 23(6). 474, 7.
33. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998, 351(9114):1451-1467. Early Breast Cancer Trialists' Collaborative Group.
34. Davies C., Pan H., Godwin J., Gray R., Arriagada R., Raina V., et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 2013, 381:805-816.
35. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. J Natl Cancer Inst 2007, 99(7):516-525.
36. Swain S.M., Jeong J.H., Geyer C.E., Costantino J.P., Pajon E.R., Fehrenbacher L., et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010, 362(22):2053-2065.
37. Gnant M., Mlineritsch B., Schippinger W., Luschin-Ebengreuth G., Postlberger S., Menzel C., et al. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 2009, 360(7):679-691.
38. Partridge A.H., Wang P.S., Winer E.P., Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003, 21(4):602-606.
39. Partridge A.H., Goldhirsch A., Gelber S., Gelber R. Breast Cancer in Young Women. Diseases of the Breast 2010, 1073-1082. Lippincott Williams & Wilkins, Philadelphia. 4th ed. L. Harris, O. Morrow (Eds.).
40. Ganz P.A., Greendale G.A., Petersen L., Kahn B., Bower J.E. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 2003, 21(22):4184-4193.
41. Dunn J., Steginga S.K. Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology 2000, 9(2):137-146.
42. Partridge A.H., Gelber S., Peppercorn J., Sampson E., Knudsen K., Laufer M., et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004, 22(20):4174-4183.
43. Leining M.G., Gelber S., Rosenberg R., Przypyszny M., Winer E.P., Partridge A.H. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006, 17(12):1777-1782.